Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/527
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCass, A.en
dc.contributor.authorKerr, P. G.en
dc.contributor.authorMasterson, R.en
dc.contributor.authorJardine, M. J.en
dc.contributor.authorPerkovic, V.en
dc.contributor.authorJun, M.en
dc.contributor.authorAgar, J. W. M.en
dc.contributor.authorGallagher, M.en
dc.contributor.authorHawley, C. M.en
dc.contributor.authorVan Eps, C.en
dc.contributor.authorGray, N.en
dc.date.accessioned2018-06-16T20:35:12Z-
dc.date.available2018-06-16T20:35:12Z-
dc.date.issued2013en
dc.identifier.citationFebruary 61, (2), 2013, p. 247-253en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/527-
dc.description.abstractBackground: Recent evidence suggests that increased frequency and/or duration of dialysis are associated with improved outcomes. We aimed to describe the outcomes associated with patients starting extended-hours hemodialysis and assess for risk factors for these outcomes. Study Design: Case series. Setting & Participants: Patients were from 6 Australian centers offering extended-hours hemodialysis. Cases were patients who started treatment for 24 hours per week or longer at any time. Outcomes: All-cause mortality, technique failure (withdrawal from extended-hours hemodialysis therapy), and access-related events. Measurements: Baseline patient characteristics (sex, primary cause of end-stage kidney disease, age, ethnicity, diabetes, and cannulation technique), presence of a vascular access-related event, and dialysis frequency. Results: 286 patients receiving extended-hours hemodialysis were identified, most of whom performed home (96%) or nocturnal (77%) hemodialysis. Most patients performed alternate-daily dialysis (52%). Patient survival rates using an intention-to-treat approach at 1, 3, and 5 years were 98%, 92%, and 83%, respectively. Of 24 deaths overall, cardiac death (n = 7) and sepsis (n = 5) were the leading causes. Technique survival rates at 1, 3, and 5 years were 90%, 77%, and 68%, respectively. Access event-free rates at the same times were 80%, 68%, and 61%, respectively. Access events significantly predicted death (HR, 2.85; 95% CI, 1.14-7.15) and technique failure (HR, 3.76; 95% CI, 1.93-7.35). Patients with glomerulonephritis had a reduced risk of technique failure (HR, 0.31; 95% CI, 0.14-0.69). Higher dialysis frequency was associated with elevated risk of developing an access event (HR per dialysis session, 1.56; 95% CI, 1.03-2.36). Limitations: Selection bias, lack of a comparator group. Conclusions: Extended-hours hemodialysis is associated with excellent survival rates and is an effective treatment option for a select group of patients. The major treatment-associated adverse events were related to complications of vascular access, particularly infection. The risk of developing vascular access complications may be increased in extended-hours hemodialysis, which may negatively affect long-term outcomes. 2013 National Kidney Foundation, Inc.<br />en
dc.languageenen
dc.relation.ispartofAmerican Journal of Kidney Diseasesen
dc.titleOutcomes of extended-hours hemodialysis performed predominantly at homeen
dc.typeArticleen
dc.identifier.doihttp://dx.doi.org/10.1053/j.ajkd.2012.08.032en
dc.subject.keywordsEnd-stage kidney diseaseextended-hours hemodialysisen
dc.subject.keywordsmortalityen
dc.subject.keywordstechnique failureen
dc.subject.keywordsvascular access eventsen
dc.subject.keywordsadulten
dc.subject.keywordsageden
dc.subject.keywordsarticleen
dc.subject.keywordsbacteremia/co [Complication]en
dc.subject.keywordscannulationen
dc.subject.keywordscase studyen
dc.subject.keywordscause of deathen
dc.subject.keywordsclinical effectivenessen
dc.subject.keywordscontinuous hemodialysisen
dc.subject.keywordsdiabetes mellitusen
dc.subject.keywordsepidemiologyen
dc.subject.keywordsethnicityen
dc.subject.keywordsevent free survivalen
dc.subject.keywordsextended hours hemodialysisen
dc.subject.keywordsfemaleen
dc.subject.keywordsglomerulonephritisen
dc.subject.keywordsheart deathen
dc.subject.keywordshemodialysis patienten
dc.subject.keywordshome dialysisen
dc.subject.keywordshumanen
dc.subject.keywordsinfection/co [Complication]en
dc.subject.keywordskidney arteriovenous fistula/co [Complication]en
dc.subject.keywordskidney failure/th [Therapy]en
dc.subject.keywordsmajor clinical studyen
dc.subject.keywordsmaleen
dc.subject.keywordsmulticenter studyen
dc.subject.keywordsrisk assessmenten
dc.subject.keywordsrisk reductionen
dc.subject.keywordssepsisen
dc.subject.keywordsstenosis/co [Complication]en
dc.subject.keywordsthrombosis/co [Complication]en
dc.subject.keywordstreatment durationen
dc.subject.keywordstreatment failureen
dc.subject.keywordstreatment outcomeen
dc.subject.keywordstreatment withdrawalen
dc.subject.keywordsvascular accessen
dc.relation.urlhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed11&AN=2013037193en
dc.identifier.risid498en
dc.description.pages247-253en
item.grantfulltextnone-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
Appears in Sites:Sunshine Coast HHS Publications
Show simple item record

Page view(s)

138
checked on Apr 24, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.